Update on Neuroendocrine Carcinomas of the Larynx.

Human papillomavirus (HPV) INSM1 Larynx Neuroendocrine carcinoma Neuroendocrine differentiation

Journal

American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470

Informations de publication

Date de publication:
04 11 2019
Historique:
pubmed: 16 8 2019
medline: 31 3 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

Laryngeal neuroendocrine carcinomas are heterogeneous neoplasms characterized by neuroendocrine differentiation. Their prognoses are dependent on tumor type, therefore different classifications have been developed. Moreover, other tumors have overlapping pathologic features posing a range of diagnostic possibilities. A review of the literature was performed to comprehensively understand the classification and diagnosis of these tumors. We review the past and present classification systems, with emphasis to the latest 2017 World Health Organization Classification of Head and Neck Tumors. We highlight salient clinicopathologic features and discuss the presumptive etiologic role of human papilloma virus. We share a practical algorithmic approach to the diagnosis of suspected neuroendocrine neoplasms of the larynx including a novel marker for neuroendocrine differentiation, insulinoma-associated protein 1. Accurate diagnosis and grading of laryngeal neuroendocrine carcinomas is critical for prognostication and therapeutic decision making. The use of an algorithm is instrumental in assuring the exclusion of mimickers.

Identifiants

pubmed: 31415081
pii: 5550288
doi: 10.1093/ajcp/aqz106
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

686-700

Informations de copyright

© American Society for Clinical Pathology, 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Carolina Strosberg (C)

Department of Pathology, Moffitt Cancer Center, Tampa, FL.

Alfio Ferlito (A)

International Head and Neck Scientific Group, Padua, Italy.

Asterios Triantafyllou (A)

Department of Pathology, Liverpool Clinical Laboratories and School of Dentistry, University of Liverpool, Liverpool, UK.

Douglas R Gnepp (DR)

Warren Alpert Medical School at Brown University, Providence, RI.

Justin A Bishop (JA)

Department of Pathology, University of Texas Southwestern Medical Center, Dallas.

Henrik Hellquist (H)

Centre for Biomedical Research, Department of Biomedical Sciences and Medicine, Faro, Portugal.
Epigenetics and Human Disease Laboratory, Department of Biomedical Sciences and Medicine, Faro, Portugal.
Algarve Biomedical Centre, Campus Gambelas, University of Algarve, Faro, Portugal.

Primoz Strojan (P)

Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia.

Stefan M Willems (SM)

Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

Göran Stenman (G)

Department of Pathology and Genetics, Sahlgrenska Cancer Center, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

Alessandra Rinaldo (A)

University of Udine School of Medicine, Udine, Italy.

Juan C Hernandez-Prera (JC)

Department of Pathology, Moffitt Cancer Center, Tampa, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH